First interim analysis of the German prospective, non-interventional study PaVe: first results on the clinical routine of ruxolitinib in polycythemia vera

被引：0
|
作者：
Griesshammer, M. [1 ]
von der Heyde, E. [2 ]
Weide, R. [3 ]
Reichert, D. [4 ]
Weniger, J. [5 ]
Schlag, R.
Hutzschenreuter, U. [6 ]
Becker, M. [7 ]
Just, M.
Hacker, E. [8 ]
Cavanna, D. [8 ]
Lengfelder, E. [9 ]
机构：
[1] Johannes Wesling Klinikum, Minden, Germany
[2] Gemeinschaftspraxis Dres Zander von der Heyde, Hannover, Germany
[3] Praxisklin Hamatol & Onkol, Koblenz, Germany
[4] Onkol Gemeinschaftspraxis Dres Reichert Janssen, Westerstede, Germany
[5] Gemeinschaftspraxis Hamatol & Onkol Dres Weniger, Erfurt, Germany
[6] Hamatol Onkol Gemeinschaftspraxis Dres Hutzschenr, Nordhorn, Germany
[7] Zentrum Hamatol & Onkol MVZ GmbH, Porta Westfalica, Germany
[8] Novartis Pharma GmbH, Nurnberg, Germany
[9] Univ Med Mannheim, Med Klin 3, Mannheim, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2017年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P544
引用
收藏
页码：148 / +
页数：2
相关论文
共 50 条
  • [11] Results of the second interim analysis of C-PATROL: A non-interventional study on olaparib within German routine clinical practice
    Marme, F.
    Hilpert, F.
    Welslau, M.
    Grabowski, J. P.
    Seitz, J.
    El-Balat, A.
    Hartkopf, A. D.
    Glowik, R.
    Sehouli, J.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 250 - 251
  • [12] Interim results of the phase IV PaVe trial (CINC424BDE12), a prospective, non-interventional study of symptoms and quality of life in polycythaemia vera patients receiving ruxolitinib therapy
    Griesshammer, M.
    Schmidt, B.
    Weide, R.
    Von der Heyde, E.
    Hutzschenreuter, U.
    Becker, M.
    Grosser, S.
    Hosseini, Khageh S.
    Weniger, J.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 99 - 100
  • [13] Efficacy of bortezomib under routine conditions. Interim results of a prospective, non-interventional study
    Overkamp, F.
    Wolf, H.
    Seipelt, G.
    Gaska, T.
    Hurtz, H.
    Kornacker, M.
    ONKOLOGIE, 2008, 31 : 125 - 125
  • [14] First interim results of IDELA PASS: a prospective non-interventional post authorization safety study of idelalisib in Germany
    Abenhardt, W.
    Knauf, W.
    Eissmann, P.
    Hucke, N.
    van Troostenburg, A.
    Watzke, S.
    Hoechstetter, M.
    Rummel, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 139 - +
  • [15] RESULTS OF THE 3RD INTERIM ANALYSIS OF C-PATROL: A NON-INTERVENTIONAL STUDY ON OLAPARIB IN GERMAN ROUTINE CLINICAL PRACTICE
    Marme, F.
    Hilpert, F.
    Welslau, M.
    Grabowski, J. P.
    Seitz, J.
    El-Balat, A.
    Hartkopf, A. D.
    Glowik, R.
    Sehouli, J.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A144 - A144
  • [16] Results of the 3rd interim analysis of C-Patrol: A non-interventional study on olaparib in German routine clinical practice
    Sehouli, J.
    Hilpert, F.
    Welslau, M. K.
    Grabowski, J. P.
    Seitz, J.
    El-Balat, A.
    Hartkopf, A.
    Glowik, R.
    Marme, F.
    ANNALS OF ONCOLOGY, 2019, 30 : 412 - 412
  • [17] First interim results from FINE-REAL: a prospective, non-interventional, phase 4 study providing insights into the use and safety of finerenone in a routine clinical setting
    Nicholas, Susanne B.
    Correa-Rotter, Ricardo
    Desai, Nihar R.
    Guo, Lixin
    Navaneethan, Sankar D.
    Pantalone, Kevin M.
    Wanner, Christoph
    Hamacher, Stefanie
    Fatoba, Samuel T.
    Horvat-Broecker, Andrea
    Garreta-Rufas, Antonio
    Gay, Alain
    Merz, Martin
    Wheeler, David C.
    JOURNAL OF NEPHROLOGY, 2024, 37 (08) : 2223 - 2232
  • [18] Effectiveness, Safety and Quality of Life with Tofacitinib Treatment in Adult Patients with Rheumatoid Arthritis Under Routine Clinical Care: First Interim Results from a German Non-Interventional, Prospective, Multi-Center Study
    Behrens, Frank
    Prothmann, Ulrich
    Klopsch, Thilo
    Holst, Ann-Doerthe
    Blindzellner, Lisa
    Behmer, Olaf
    Klaus, Pascal
    Meng, Thomas
    Loeschmann, Peter-Andreas
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [19] TOCILIZUMAB ADMINISTERED IN DAILY CLINICAL PRACTICE - FINAL RESULTS OF THE GERMAN NON-INTERVENTIONAL STUDY "ROUTINE"
    Burmester, G. -R.
    von Hinueber, U.
    Richter, C.
    Schwenke, H.
    Guertler, I.
    Kaestner, P.
    Peters, M. A.
    Iking-Konert, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 452 - 452
  • [20] "Real-world" data on the use of ruxolitinib in myelofibrosis: 2018 interim analysis of the prospective, non-interventional study JAKoMo
    Koschmieder, S.
    Jacobasch, L.
    Schulte, C.
    Geer, T.
    Brudler, O.
    Wehmeyer, J.
    Klausmann, M.
    Groeschl, B.
    Grosser, S.
    Pahl, H. L.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 98 - 99
12345